Mandatory notification of trade - Høie
Lars Høie has on 4 October 2016 sold 10,150,000 shares and has also been allocated 113,870,152 new shares in the rights offering in Bionor Pharma ASA (the "Company").
STOCK EXCHANGE ANNOUNCEMENT
Following these transactions Lars Høie holds 128,973,522 shares, equalling 9.31% of the then issued share capital. Lars Høie further owns 15,253,370 warrants in the Company. His total holding of shares and warrants equals 10.41% based on the new share capital following registration of the new shares issued in the Rights Offering.
This information is subject to the disclosure requirements set out in section 4-3 of the Norwegian Securities Trading Act.
Link to the announcement in pdf